We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
Cap. Flow
+$35M
Cap. Flow %
2.96%
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.9M
2
HQY icon
HealthEquity
HQY
+$22.9M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$15.2M
4
GSK icon
GSK
GSK
+$13.4M
5
TSVT
2seventy bio
TSVT
+$9.53M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29M
2
CTLT
CATALENT, INC.
CTLT
+$15.5M
3
ICLR icon
Icon
ICLR
+$12.8M
4
ABCM
Abcam PLC
ABCM
+$12.2M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$9.77M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Miscellaneous 23.9%
3 Communication Services 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRY icon
76
ARS Pharmaceuticals
SPRY
$586M
– –
-48,788
Closed -$327K
URGN icon
77
UroGen Pharma
URGN
$2.13B
– –
-74,797
Closed -$774K
XENE icon
78
Xenon Pharmaceuticals
XENE
$5.81B
– –
-171,378
Closed -$6.6M
ZLAB icon
79
Zai Lab
ZLAB
$2.93B
– –
-55,176
Closed -$1.53M
CTLT
80
DELISTED
CATALENT, INC.
CTLT
– –
-356,875
Closed -$15.5M
MODN
81
DELISTED
MODEL N, INC.
MODN
– –
-223,168
Closed -$7.89M
ABCM
82
DELISTED
Abcam PLC
ABCM
– –
-499,394
Closed -$12.2M
PRTK
83
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-1,327,857
Closed -$2.93M
1 2 3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
  • Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
  • Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
  • Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
  • Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
  • Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.